Physician profile
Bruce Dodt
NPI 1013059005
$15,546.25
in general payments reported to CMS, 2019-2025
75 companies · $2,528 in 2025
The $2,528 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,990 · 2020: $1,310 · 2021: $1,530 · 2022: $1,794 · 2023: $2,803 · 2024: $2,592 · 2025: $2,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,922.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,429.19 | 2019-2025 | Ubrelvy, Qulipta, Botox |
| Novartis Pharmaceuticals Corporation | $1,032.98 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $813.75 | 2019-2024 | Qelbree |
| Ucb, INC. | $659.55 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Csl Behring | $641.63 | 2019-2025 | Hizentra |
| Emd Serono, INC. | $617.69 | 2019-2023 | Mavenclad |
| Biogen, INC. | $608.38 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Livanova USA, INC. | $566.50 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $545.65 | 2019-2024 | Aimovig |
| Mdd US Operations, LLC | $509.91 | 2019-2025 | Apokyn |
| Lilly USA, LLC | $503.20 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Genentech USA, INC. | $458.21 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Teva Pharmaceuticals USA, INC. | $456.23 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amneal Pharmaceuticals LLC | $436.52 | 2019-2025 | Crexont, Rytary |
| Argenx US, INC. | $309.49 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
Show all 75 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Dodt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.